NCT03980756View on ClinicalTrials.gov

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

April 27, 2020

Study Completion Date

June 18, 2020

Conditions
Gastritis
Interventions
DRUG

AD-206 20mg

1 tablet administered before the breakfast during 7 days

DRUG

Esomeprazole 20mg

1 tablet administered before the breakfast during 7 days

DRUG

AD-206 40mg

1 tablet administered before the breakfast during 7 days

DRUG

Esomeprazole 40mg

1 tablet administered before the breakfast during 7 days

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Addpharma Inc.

INDUSTRY

NCT03980756 - A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole | Biotech Hunter | Biotech Hunter